Biotricity Historical Income Statement

BTCY Stock  USD 1.48  0.12  8.82%   
Historical analysis of Biotricity income statement accounts such as Interest Expense of 2 M, Selling General Administrative of 21.3 M or Other Operating Expenses of 30.2 M can show how well Biotricity performed in making a profits. Evaluating Biotricity income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Biotricity's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Biotricity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biotricity is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

About Biotricity Income Statement Analysis

Biotricity Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Biotricity shareholders. The income statement also shows Biotricity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Biotricity Income Statement Chart

Biotricity Income Statement is one of the three primary financial statements used for reporting Biotricity's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Biotricity revenue and expense. Biotricity Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Other Operating Expenses is likely to rise to about 30.2 M in 2024, whereas Depreciation And Amortization is likely to drop 6,504 in 2024.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Biotricity. It is also known as Biotricity overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Biotricity's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Other Operating Expenses is likely to rise to about 30.2 M in 2024, whereas Depreciation And Amortization is likely to drop 6,504 in 2024.

Biotricity income statement Correlations

-0.130.080.03-0.28-0.280.050.280.07-0.160.34-0.16-0.43-0.10.240.25
-0.130.650.63-0.71-0.710.57-0.760.64-0.85-0.87-0.850.86-0.86-0.98-0.11
0.080.651.0-0.95-0.950.97-0.841.0-0.92-0.61-0.920.56-0.92-0.58-0.61
0.030.631.0-0.93-0.930.98-0.851.0-0.9-0.6-0.90.55-0.9-0.57-0.63
-0.28-0.71-0.95-0.931.0-0.910.78-0.950.970.60.97-0.530.950.620.36
-0.28-0.71-0.95-0.931.0-0.910.78-0.950.970.60.97-0.530.950.620.36
0.050.570.970.98-0.91-0.91-0.860.98-0.87-0.56-0.870.51-0.85-0.5-0.65
0.28-0.76-0.84-0.850.780.78-0.86-0.850.830.840.83-0.810.840.710.48
0.070.641.01.0-0.95-0.950.98-0.85-0.92-0.6-0.920.56-0.91-0.57-0.61
-0.16-0.85-0.92-0.90.970.97-0.870.83-0.920.741.0-0.690.990.780.31
0.34-0.87-0.61-0.60.60.6-0.560.84-0.60.740.74-0.980.760.840.22
-0.16-0.85-0.92-0.90.970.97-0.870.83-0.921.00.74-0.690.990.780.31
-0.430.860.560.55-0.53-0.530.51-0.810.56-0.69-0.98-0.69-0.71-0.86-0.25
-0.1-0.86-0.92-0.90.950.95-0.850.84-0.910.990.760.99-0.710.80.35
0.24-0.98-0.58-0.570.620.62-0.50.71-0.570.780.840.78-0.860.80.11
0.25-0.11-0.61-0.630.360.36-0.650.48-0.610.310.220.31-0.250.350.11
Click cells to compare fundamentals

Biotricity Account Relationship Matchups

Biotricity income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization10.7M12.7M2.3K6.0K6.8K6.5K
Interest Expense92.4K2.5M10.6M2.6M3.0M2.0M
Selling General Administrative10.1M12.6M18.6M17.6M20.3M21.3M
Other Operating Expenses12.3M16.7M24.4M25.0M28.8M30.2M
Operating Income(10.9M)(13.4M)(17.9M)(15.6M)(14.0M)(13.3M)
Ebit(10.9M)(13.4M)(17.9M)(15.6M)(14.0M)(13.3M)
Research Development1.4M2.1M2.7M3.2M3.7M3.9M
Ebitda(246.8K)(707.1K)(17.9M)(15.6M)(14.0M)(13.3M)
Total Operating Expenses11.4M14.6M21.3M20.9M24.0M25.2M
Income Before Tax(11.1M)(15.5M)(29.1M)(18.7M)(16.8M)(16.0M)
Total Other Income Expense Net(43.8K)341.8K(1.8M)(665.8K)(599.2K)(569.3K)
Net Income(11.1M)(15.5M)(29.1M)(18.7M)(16.8M)(16.0M)
Income Tax Expense(400.0K)(2.8M)9.4M2.4M2.8M2.9M
Total Revenue1.4M3.4M7.7M9.6M11.1M11.6M
Gross Profit485.8K1.3M4.6M5.4M6.3M6.6M
Net Income From Continuing Ops(11.1M)(15.5M)(29.1M)(18.7M)(16.8M)(17.6M)
Cost Of Revenue932.0K2.1M3.1M4.2M4.8M5.1M
Net Income Applicable To Common Shares(8.6M)(11.3M)(16.5M)(30.2M)(27.2M)(25.8M)
Net Interest Income(92.4K)(2.5M)(9.3M)(2.6M)(2.3M)(2.4M)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotricity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotricity's short interest history, or implied volatility extrapolated from Biotricity options trading.

Pair Trading with Biotricity

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.

Moving against Biotricity Stock

  0.71MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.54TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.53AHG Akso Health GroupPairCorr
  0.51SSY SunLink Health SystemsPairCorr
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
1.319
Quarterly Revenue Growth
0.209
Return On Assets
(0.95)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.